Comorbidities and polypharmacy are often common in older individuals who present with overactive bladder (OAB); patients may need to be screened for other possible causes of urinary urgency. First-line therapy for OAB is always lifestyle interventions. Second–line treatments include antimuscarinics or a beta-3 adrenergic agent. Moreover, a combination of changes in lifestyle with drug therapy may be more effective than either treatment on its own in older individuals. This case report describes in detail treatment selection, and the adjustments that often must be considered and implemented, in an older patient with OAB who presents with multiple comorbidities.
Provided by Global Education Group in collaboration With Haymarket Medical Education.
Supported by an educational grant from Astellas.
Martin Wehling, MD
Professor of Clinical Pharmacology
University of Heidelberg
Martin Wehling, MD, is a consultant for and on the speakers bureau for Pfizer.
Publishing Staff Disclosures
Susan Basilico, Angie Ladas, and Nick Zittell have nothing to disclose.
Physician Credit: Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nursing Credit: Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation Statement(s)
Physician Credit Designation: Global Education Group designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Designation: This educational activity for 0.50 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Astellas or Global Education Group. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. If you have any questions relating to the accreditation of this activity, please contact Global at 303-395-1782 or firstname.lastname@example.org
Method of Participation Instructions
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate.
COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.